主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SPRC
#6742
SciSparc Ltd. Ordinary Shares
0.5
6
-3.45%
版块:
基础:
利润货币:
日范围
年范围
日变化
-3.45%
每月变动
-36.36%
6个月变化
-88.26%
年变化
+51.35%
前一天收盘价
0.5
8
Open
0.5
6
Bid
Ask
Low
0.5
6
High
0.5
6
交易量
1
市场
股票
医疗保健
SPRC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
265.84 K
5 662.53
12.45 K
33.65 K
515.63 K
567.4 K
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
1.38
0.58
0.24
0.53
0.72
—
Return on equity %
2.47
0.71
0.4
0.61
0.84
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
76.1
76.28
38.74
—
Operating margin %
—
—
615.22
236.71
560.18
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
192.43
204.34
572.13
—
Liquidity ratios
Quick ratio
—
—
0.92
3.63
5.28
—
Current ratio
2.25
5.59
1.09
4.1
5.36
—
Inventory turnover
—
—
0.48
0.97
1.87
—
Asset turnover
—
—
0.13
0.26
0.12
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
新闻
SciSparc 자회사, 항생제 강화 기술 미국 특허 취득
SciSparc subsidiary receives U.S. patent for antibiotic-enhancing cannabinoid technology
SciSparc, GERD 의료기기 시장 진출 위해 MUSE 시스템 IP 인수
SciSparc acquires MUSE system IP portfolio to enter GERD device market
SciSparc, Xylo로부터 MUSE 내시경 시스템 특허 인수 계약 체결
SciSparc to acquire MUSE endoscopic system patents from Xylo
SciSparc Moves Into Endoscopy With Strategic Patent Deal - SciSparc (NASDAQ:SPRC)
SciSparc, 나스닥 자본금 요건 미충족 통보 받아
SciSparc receives Nasdaq non-compliance notice for stockholders’ equity
SciSparc 자회사, 이스라엘에서 오피오이드 기술 특허 획득
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech
IM Cannabis, 아시 레비 신임 CFO 임명